On July 7, 2025, Bunge Global SA (NYSE: BG) announced the expiration and final results of its previously announced exchange offers and consent solicitations.
Summary Bunge Global SA (BG) has announced the successful expiration and final results of its exchange offers and consent solicitations, conducted by its subsid
Bunge Global SA (NYSE: BG) (”Bunge”), today announced the expiration and final results of the previously announced (A) offers to exchange (each an ”Excha
Bunge Global SA (BG), through its wholly owned subsidiary Bunge Limited Finance Corp. (BLFC), has entered into a significant Term Loan Agreement on June 30, 2
Bunge Global SA (BG) has announced significant amendments to its existing credit agreements, aimed at bolstering its financial flexibility and supporting its
Bunge Limited (BG) has outlined its 2025 financial expectations while excluding the effects of anticipated acquisitions and divestitures set to finalize this ye
Bunge Global SA (BG) has announced an extension of the expiration date for its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), regarding its ongo
Bunge Global SA (NYSE: BG) (”Bunge”), today announced that its wholly-owned subsidiary, Bunge Limited Finance Corp. (”BLFC”), has further extended the
Fred Craves, Ph.D. to retire from Madrigal's Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals
Bunge Global SA (BG) has announced an extension of the expiration date for its ongoing exchange offers and consent solicitations, a strategic move linked to i
Bunge Global SA (BG) has announced an extension of the expiration date for its ongoing exchange offers and consent solicitations, a strategic move linked to i
Canada is considering export taxes on goods, including uranium, oil and potash, if President-elect Donald Trump imposes the broad tariffs he has pledged.